| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A pooled analysis of bone marrow micrometastasis in breast cancer.
|
N Engl J Med
|
2005
|
6.86
|
|
2
|
Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
|
Clin Cancer Res
|
2007
|
6.59
|
|
3
|
Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.
|
Breast Cancer Res
|
2010
|
2.98
|
|
4
|
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.
|
Breast Cancer Res Treat
|
2010
|
2.12
|
|
5
|
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
|
Cancer
|
2006
|
1.82
|
|
6
|
Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials.
|
Cancer Metastasis Rev
|
2013
|
1.82
|
|
7
|
[Hemangiosarcoma after breast-conserving therapy of breast cancer: report of four cases with molecular genetic diagnosis and literature review].
|
Strahlenther Onkol
|
2011
|
1.51
|
|
8
|
Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
|
Onkologie
|
2009
|
1.51
|
|
9
|
Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
|
Clin Cancer Res
|
2006
|
1.46
|
|
10
|
Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
|
Carcinogenesis
|
2013
|
1.28
|
|
11
|
The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study.
|
Breast Cancer Res
|
2012
|
1.22
|
|
12
|
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.
|
Breast Cancer Res
|
2012
|
1.21
|
|
13
|
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
|
Anticancer Res
|
2010
|
1.18
|
|
14
|
Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
|
Breast Cancer Res Treat
|
2010
|
1.15
|
|
15
|
The prognostic impact of circulating tumor cells in subtypes of metastatic breast cancer.
|
Breast Cancer Res Treat
|
2012
|
1.11
|
|
16
|
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients.
|
Proc Natl Acad Sci U S A
|
2013
|
1.02
|
|
17
|
Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.
|
BMC Cancer
|
2011
|
1.02
|
|
18
|
Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.
|
Clin Cancer Res
|
2012
|
1.01
|
|
19
|
The German SUCCESS C Study - The First European Lifestyle Study on Breast Cancer.
|
Breast Care (Basel)
|
2010
|
0.97
|
|
20
|
Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.
|
Arch Gynecol Obstet
|
2011
|
0.96
|
|
21
|
Comparison of total laparoscopic, vaginal and abdominal hysterectomy.
|
Arch Gynecol Obstet
|
2007
|
0.95
|
|
22
|
Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.
|
BMC Cancer
|
2013
|
0.95
|
|
23
|
Docetaxel-containing adjuvant chemotherapy in patients with early stage breast cancer. Consistency of effect independent of nodal and biomarker status: a meta-analysis of 14 randomized clinical trials.
|
Breast Cancer Res Treat
|
2012
|
0.93
|
|
24
|
Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.
|
Breast Cancer Res
|
2011
|
0.93
|
|
25
|
Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer.
|
Breast Care (Basel)
|
2010
|
0.92
|
|
26
|
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).
|
Breast Care (Basel)
|
2009
|
0.92
|
|
27
|
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database.
|
Eur J Cancer
|
2012
|
0.92
|
|
28
|
Prognostic value of nodal ratios in node-positive breast cancer: a compiled update.
|
Future Oncol
|
2009
|
0.91
|
|
29
|
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
|
Breast Cancer Res
|
2008
|
0.91
|
|
30
|
Prognostic impact of Thomsen-Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients.
|
Breast Cancer Res Treat
|
2006
|
0.91
|
|
31
|
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
|
Breast Cancer Res Treat
|
2003
|
0.90
|
|
32
|
Is the histomorphological concept of the female pelvic floor and its changes due to age and vaginal delivery correct?
|
Neurourol Urodyn
|
2005
|
0.88
|
|
33
|
Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients.
|
BMC Cancer
|
2013
|
0.88
|
|
34
|
Analysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patients.
|
Mol Oncol
|
2013
|
0.88
|
|
35
|
The effect of overweight and nutrition on prognosis in breast cancer.
|
Dtsch Arztebl Int
|
2011
|
0.87
|
|
36
|
Practical management of everolimus-related toxicities in patients with advanced solid tumors.
|
Onkologie
|
2013
|
0.87
|
|
37
|
Survey of compartment syndrome of the lower extremity after gynecological operations.
|
Langenbecks Arch Surg
|
2014
|
0.86
|
|
38
|
Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
|
Clin Exp Metastasis
|
2008
|
0.86
|
|
39
|
International study on inter-reader variability for circulating tumor cells in breast cancer.
|
Breast Cancer Res
|
2014
|
0.86
|
|
40
|
Comparison of circulating tumor cells (CTC) in peripheral blood and disseminated tumor cells in the bone marrow (DTC-BM) of breast cancer patients.
|
J Cancer Res Clin Oncol
|
2013
|
0.85
|
|
41
|
Pooled analysis of the prognostic relevance of progesterone receptor status in five German cohort studies.
|
Breast Cancer Res Treat
|
2014
|
0.85
|
|
42
|
The paravertebral lamina technique: a new regional anesthesia approach for breast surgery.
|
J Clin Anesth
|
2011
|
0.84
|
|
43
|
CTCs in primary breast cancer (I).
|
Recent Results Cancer Res
|
2012
|
0.84
|
|
44
|
Syndecan-1 knock-down in decidualized human endometrial stromal cells leads to significant changes in cytokine and angiogenic factor expression patterns.
|
Reprod Biol Endocrinol
|
2010
|
0.83
|
|
45
|
Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
|
Arch Gynecol Obstet
|
2008
|
0.83
|
|
46
|
Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
|
Histochem Cell Biol
|
2008
|
0.82
|
|
47
|
Systemic administration of bevacizumab prolongs survival in an in vivo model of platinum pre-treated ovarian cancer.
|
Oncol Lett
|
2012
|
0.82
|
|
48
|
Characterisation of disseminated tumor cells in the bone marrow of breast cancer patients by the Thomsen-Friedenreich tumor antigen.
|
Histochem Cell Biol
|
2005
|
0.82
|
|
49
|
Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.
|
J Cancer Res Clin Oncol
|
2012
|
0.81
|
|
50
|
Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
|
Breast Cancer Res
|
2005
|
0.79
|
|
51
|
Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy.
|
Breast
|
2003
|
0.79
|
|
52
|
German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer.
|
Eur J Cancer
|
2013
|
0.79
|
|
53
|
Expression of glycodelin in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastases.
|
Anticancer Res
|
2005
|
0.79
|
|
54
|
Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.78
|
|
55
|
Recurrent Mastitis after Core Needle Biopsy: Case Report of an Unusual Complication after Core Needle Biopsy of a Phyllodes Tumor.
|
Breast Care (Basel)
|
2012
|
0.77
|
|
56
|
Expression of the vascular endothelial growth factor receptor neuropilin-1 at the human embryo-maternal interface.
|
Eur J Obstet Gynecol Reprod Biol
|
2010
|
0.77
|
|
57
|
Failure of Implanon contraception in a patient taking carbamazepin for epilepsia.
|
Arch Gynecol Obstet
|
2005
|
0.77
|
|
58
|
[Current standards in the treatment of breast cancer].
|
Med Monatsschr Pharm
|
2011
|
0.77
|
|
59
|
Treatment of chemotherapy resistant ovarian cancer with a MDR1 targeted oncolytic adenovirus.
|
Gynecol Oncol
|
2011
|
0.77
|
|
60
|
Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.
|
BMC Cancer
|
2013
|
0.77
|
|
61
|
Presence of disseminated tumor cells in bone marrow correlates with tumor stage and nodal involvement in cervical cancer patients.
|
Int J Cancer
|
2013
|
0.77
|
|
62
|
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
|
Oncology
|
2016
|
0.76
|
|
63
|
Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence.
|
Oncol Rep
|
2005
|
0.76
|
|
64
|
Phase III study on efficacy of taxanes plus bevacizumab with or without capecitabine as first-line chemotherapy in metastatic breast cancer.
|
Breast Cancer Res Treat
|
2014
|
0.76
|
|
65
|
ABC1 Consensus Conference - a German Perspective: First International Consensus Conference on Advanced Breast Cancer (ABC1), Lisbon, November 5, 2011.
|
Breast Care (Basel)
|
2012
|
0.76
|
|
66
|
Unexpected metastatic lobular carcinoma of the breast with intraabdominal spread and subsequent port-site metastasis after diagnostic laparoscopy for exclusion of ovarian cancer.
|
Gynecol Oncol
|
2004
|
0.76
|
|
67
|
Aesthetic result among breast cancer patients undergoing autologous breast reconstruction versus breast conserving therapy.
|
Arch Gynecol Obstet
|
2006
|
0.76
|
|
68
|
The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.
|
Strahlenther Onkol
|
2009
|
0.76
|
|
69
|
The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancy.
|
Gynecol Oncol
|
2013
|
0.75
|
|
70
|
Fertility preservation after caesarean delivery in a woman diagnosed with Morbus Hodgkin disease during pregnancy.
|
J Assist Reprod Genet
|
2013
|
0.75
|
|
71
|
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
|
Breast Care (Basel)
|
2012
|
0.75
|
|
72
|
Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques.
|
Arch Gynecol Obstet
|
2015
|
0.75
|
|
73
|
Benefits and risks of breast cancer screening.
|
Oncol Res Treat
|
2014
|
0.75
|
|
74
|
Management of skin-sparing mastectomy: results of a survey of German hospitals.
|
Onkologie
|
2006
|
0.75
|
|
75
|
Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy?
|
Oncology
|
2017
|
0.75
|
|
76
|
Guidelines are advantageous, though not essential for improved survival among breast cancer patients.
|
Breast Cancer Res Treat
|
2015
|
0.75
|
|
77
|
Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions.
|
Oncol Res Treat
|
2016
|
0.75
|
|
78
|
Parachuting and pregnancy: what do we know about pregnant skydivers and the risks they are taking?
|
Clin J Sport Med
|
2014
|
0.75
|
|
79
|
Influencing factors for regional lymph node recurrence of breast cancer.
|
Arch Gynecol Obstet
|
2007
|
0.75
|
|
80
|
Prevalence of CA 27.29 in primary breast cancer patients before the start of systemic treatment.
|
Anticancer Res
|
2010
|
0.75
|
|
81
|
The risk of urinary incontinence after partial urethral resection in patients with anterior vulvar cancer.
|
Eur J Obstet Gynecol Reprod Biol
|
2010
|
0.75
|
|
82
|
[Metformin for the treatment of polycystic ovary syndrome].
|
Med Monatsschr Pharm
|
2016
|
0.75
|
|
83
|
Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer.
|
Recent Results Cancer Res
|
2003
|
0.75
|
|
84
|
Treatment cost evaluation of extrauterine gravidity: a literature review of medical and surgical treatment costs.
|
Arch Gynecol Obstet
|
2014
|
0.75
|
|
85
|
[Reproductive aging].
|
MMW Fortschr Med
|
2012
|
0.75
|
|
86
|
[Research for breast cancer patients. Progress on a broad front (interview by Dr. med. Jochen Aumiller)].
|
MMW Fortschr Med
|
2009
|
0.75
|
|
87
|
Comparison of Fetomaternal Outcome between 47 Deliveries Following Successful External Cephalic Version for Breech Presentation and 7456 Deliveries Following Spontaneous Cephalic Presentation.
|
Gynecol Obstet Invest
|
2017
|
0.75
|